|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.20 EUR | -0.37% |
|
-1.57% | -6.09% |
| 01-23 | JCDecaux, Sanofi, Sword Group... Stocks to Watch Today in Paris | |
| 01-23 | French and Benelux stocks-Factors to watch On 23 Jan | RE |
| Capitalization | 5.89B 6.93B 5.46B 5.1B 9.51B 636B 10.08B 62.39B 24.77B 300B 25.97B 25.44B 1,093B | P/E ratio 2025 * |
8.65x | P/E ratio 2026 * | 9.83x |
|---|---|---|---|---|---|
| Enterprise value | 12.78B 15.02B 11.84B 11.07B 20.63B 1,380B 21.86B 135B 53.73B 652B 56.33B 55.17B 2,370B | EV / Sales 2025 * |
12.5x | EV / Sales 2026 * | 12.3x |
| Free-Float |
67.31% | Yield 2025 * |
6.95% | Yield 2026 * | 7.12% |
Last Transcript: Covivio
| 1 day | -0.37% | ||
| 1 week | -1.57% | ||
| Current month | -6.09% | ||
| 1 month | -4.23% | ||
| 3 months | -7.72% | ||
| 6 months | -3.45% | ||
| Current year | -6.09% |
| 1 week | 52.4 | 53.85 | |
| 1 month | 52.4 | 56.7 | |
| Current year | 52.4 | 56.6 | |
| 1 year | 43.4 | 59.85 | |
| 3 years | 36.26 | 66.6 | |
| 5 years | 36.26 | 82.14 | |
| 10 years | 36.26 | 112.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 30/01/2011 | |
Paul Arkwright
DFI | Director of Finance/CFO | 40 | 30/06/2021 |
| Chief Operating Officer | 53 | 31/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 30/09/2001 | |
Romolo Bardin
BRD | Director/Board Member | 47 | 16/04/2015 |
| Chairman | 72 | 20/07/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.37% | -1.57% | +8.17% | -14.19% | 6.93B | ||
| -0.18% | -1.11% | +12.21% | -9.25% | 55.88B | ||
| -0.18% | -0.66% | +20.13% | +55.83% | 15.33B | ||
| -0.42% | -2.07% | +21.65% | +12.92% | 14.07B | ||
| -0.76% | -2.41% | +2.07% | -9.61% | 13.4B | ||
| -0.12% | -1.81% | +15.93% | +38.90% | 10.93B | ||
| -0.35% | +0.70% | +11.63% | +2.86% | 10.4B | ||
| +2.75% | +3.11% | -40.58% | -62.47% | 10.32B | ||
| Average | +0.05% | -0.94% | +6.40% | +1.87% | 17.16B | |
| Weighted average by Cap. | -0.04% | -1.03% | +9.15% | +0.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.02B 1.2B 947M 885M 1.65B 110B 1.75B 10.82B 4.3B 52.12B 4.5B 4.41B 190B | 1.05B 1.24B 974M 910M 1.7B 114B 1.8B 11.13B 4.42B 53.6B 4.63B 4.54B 195B |
| Net income | 842M 991M 781M 730M 1.36B 91.01B 1.44B 8.92B 3.54B 42.97B 3.71B 3.64B 156B | 722M 849M 669M 625M 1.17B 77.98B 1.24B 7.65B 3.04B 36.82B 3.18B 3.12B 134B |
| Net Debt | 6.89B 8.1B 6.38B 5.96B 11.12B 744B 11.78B 72.94B 28.96B 351B 30.36B 29.74B 1,278B | 7B 8.23B 6.48B 6.06B 11.3B 756B 11.97B 74.11B 29.42B 357B 30.84B 30.21B 1,298B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 53.20 € | -0.37% | 84,281 |
| 22/01/26 | 53.40 € | +1.91% | 102,830 |
| 21/01/26 | 52.40 € | -1.41% | 113,013 |
| 20/01/26 | 53.15 € | -1.12% | 120,803 |
| 19/01/26 | 53.75 € | -0.56% | 87,177 |
Real-time Euronext Paris, January 23, 2026 at 04:55 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- COV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















